Miragen Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.3M | 382k | 21.78 |
| 2023-09-30 | $6.1M | 399k | 15.34 |
| 2023-06-30 | $7.5M | 316k | 23.79 |
| 2023-03-31 | $9.0M | 355k | 25.44 |
| 2022-12-31 | $7.1M | 244k | 29.21 |
| 2022-03-31 | $1.2M | 67k | 18.48 |